These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 20660053)
1. Reversible sympathetic overactivity in hypertensive patients with primary aldosteronism. Kontak AC; Wang Z; Arbique D; Adams-Huet B; Auchus RJ; Nesbitt SD; Victor RG; Vongpatanasin W J Clin Endocrinol Metab; 2010 Oct; 95(10):4756-61. PubMed ID: 20660053 [TBL] [Abstract][Full Text] [Related]
2. Normal sympathetic vasomotor and cardiac parasympathetic activities in patients with primary aldosteronism: assessment by spectral analysis. Munakata M; Imai Y; Hashimoto J; Omata K; Nakao M; Yamamoto M; Abe K J Auton Nerv Syst; 1995 Apr; 52(2-3):213-23. PubMed ID: 7615899 [TBL] [Abstract][Full Text] [Related]
3. Does infusion of ANG II increase muscle sympathetic nerve activity in patients with primary aldosteronism? Matsukawa T; Miyamoto T Am J Physiol Regul Integr Comp Physiol; 2008 Jun; 294(6):R1873-9. PubMed ID: 18367653 [TBL] [Abstract][Full Text] [Related]
4. Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases. Médeau V; Moreau F; Trinquart L; Clemessy M; Wémeau JL; Vantyghem MC; Plouin PF; Reznik Y Clin Endocrinol (Oxf); 2008 Jul; 69(1):20-8. PubMed ID: 18284637 [TBL] [Abstract][Full Text] [Related]
6. The sympathetic nervous system and hypertension in primary aldosteronism. Bravo EL; Tarazi RC; Dustan HP; Fouad FM Hypertension; 1985; 7(1):90-6. PubMed ID: 3980062 [TBL] [Abstract][Full Text] [Related]
7. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Schlaich MP; Kaye DM; Lambert E; Sommerville M; Socratous F; Esler MD Circulation; 2003 Aug; 108(5):560-5. PubMed ID: 12847071 [TBL] [Abstract][Full Text] [Related]
8. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma. Lin YH; Lin LY; Chen A; Wu XM; Lee JK; Su TC; Wu VC; Chueh SC; Lin WC; Lo MT; Wang PC; Ho YL; Wu KD; Atherosclerosis; 2012 Mar; 221(1):154-9. PubMed ID: 22197109 [TBL] [Abstract][Full Text] [Related]
9. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Miyajima E; Yamada Y; Yoshida Y; Matsukawa T; Shionoiri H; Tochikubo O; Ishii M Hypertension; 1991 Jun; 17(6 Pt 2):1057-62. PubMed ID: 1828457 [TBL] [Abstract][Full Text] [Related]
10. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447 [TBL] [Abstract][Full Text] [Related]
11. Risk of sepsis in patients with primary aldosteronism. Chan CK; Hu YH; Chen L; Chang CC; Lin YF; Lai TS; Huang KH; Lin YH; Wu VC; Wu KD; Crit Care; 2018 Nov; 22(1):313. PubMed ID: 30463626 [TBL] [Abstract][Full Text] [Related]
12. Decreased blood pressure variability at rest in patients with primary aldosteronism. Munakata M; Aihara A; Imai Y; Abe K; Yoshinaga K Am J Hypertens; 1998 Jul; 11(7):828-38. PubMed ID: 9683044 [TBL] [Abstract][Full Text] [Related]
13. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases]. Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213 [TBL] [Abstract][Full Text] [Related]
15. Primary aldosteronism: Higher volume load, cardiac output and arterial stiffness than in essential hypertension. Choudhary MK; Värri E; Matikainen N; Koskela J; Tikkakoski AJ; Kähönen M; Niemelä O; Mustonen J; Nevalainen PI; Pörsti I J Intern Med; 2021 Jan; 289(1):29-41. PubMed ID: 32463949 [TBL] [Abstract][Full Text] [Related]
16. Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism. Matsumoto T; Oki K; Kajikawa M; Nakashima A; Maruhashi T; Iwamoto Y; Iwamoto A; Oda N; Hidaka T; Kihara Y; Kohno N; Chayama K; Goto C; Aibara Y; Noma K; Liao JK; Higashi Y Hypertension; 2015 Apr; 65(4):841-8. PubMed ID: 25624340 [TBL] [Abstract][Full Text] [Related]
17. Withdrawal of endogenous sympathetic drive lowers blood pressure in primary aldosteronism. Nicholls MG; Julius S; Zweifler AJ Clin Endocrinol (Oxf); 1981 Sep; 15(3):253-8. PubMed ID: 6975670 [TBL] [Abstract][Full Text] [Related]
18. Preeclampsia -- a state of sympathetic overactivity. Schobel HP; Fischer T; Heuszer K; Geiger H; Schmieder RE N Engl J Med; 1996 Nov; 335(20):1480-5. PubMed ID: 8890098 [TBL] [Abstract][Full Text] [Related]
19. Twenty-Four hour blood pressure profile in subjects with different subtypes of primary aldosteronism. Zelinka T; Widimský J Physiol Res; 2001; 50(1):51-7. PubMed ID: 11300227 [TBL] [Abstract][Full Text] [Related]
20. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Rossi GP; Bolognesi M; Rizzoni D; Seccia TM; Piva A; Porteri E; Tiberio GA; Giulini SM; Agabiti-Rosei E; Pessina AC Hypertension; 2008 May; 51(5):1366-71. PubMed ID: 18347224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]